(Hypertension. 1997;30:928-933.)
© 1997 American Heart Association, Inc.
Articles |
From the Departments of Medicine, The University of Texas Health Science Center, Houston (A.M.K., A.H., T.S.), and Baylor College of Medicine (J.C.A.), Houston, Tex.
Correspondence to Andrew M. Kahn, MD, 4.138 MSB, University of Texas Health Science Center, PO Box 20708, Houston, TX 77225.
Abstract Insulin acutely decreases contractile agonist-induced Ca2+ influx and contraction in endothelium-free cultured vascular smooth muscle (VSM) cells, but the mechanism is not known. Since it has been reported that insulin-induced vasodilation in humans is linked to nitric oxide synthase activity, we wished to determine whether insulin inhibits Ca2+ influx and contraction of cultured vascular smooth muscle cells by a nitric oxide synthasedependent pathway. Primary cultures of endothelial cellfree VSM cells from canine femoral artery were preincubated with and without 1 nmol/L insulin for 30 minutes, and the 5-minute production of cGMP was measured. Insulin alone did not affect cGMP production, but in the presence of 10-5 mol/L serotonin insulin stimulated cGMP production by 60%. NG-monomethyl-L-arginine (0.1 mmol/L), an inhibitor of nitric oxide synthase, inhibited the conversion of arginine to citrulline by these cells, blocked insulin-stimulated cGMP production, and blocked the inhibition by insulin of 5-hydroxytryptamine (5-HT)stimulated Mn+2 (a Ca2+ surrogate) influx and contraction. Insulin did not affect contraction of VSM cells grown under conditions designed to deplete the cells of tetrahydrobiopterin, an essential cofactor of nitric oxide synthase. These studies demonstrate that insulin acutely inhibits 5-HTstimulated Ca2+ influx and contraction of endothelium-free cultured VSM cells by a nitric oxide synthasedependent mechanism.
Key Words: serotonin cyclic GMP fura-2 Ca2+ transport arginine
This article has been cited by other articles:
![]() |
J. H. Lee, T. Palaia, and L. Ragolia Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation Am J Physiol Cell Physiol, February 1, 2009; 296(2): C327 - C338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, S. Xia, and L. Ragolia Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R144 - R154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee and L. Ragolia AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1355 - C1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Okon, A. W.Y. Chung, P. Rauniyar, E. Padilla, T. Tejerina, B. M. McManus, H. Luo, and C. van Breemen Compromised Arterial Function in Human Type 2 Diabetic Patients Diabetes, August 1, 2005; 54(8): 2415 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, Y. Yang, S. Zhang, and A. M. Kahn Insulin-Stimulated Hydrogen Peroxide Increases Guanylate Cyclase Activity in Vascular Smooth Muscle Hypertension, October 1, 2003; 42(4): 569 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kahn, J. C. Allen, C. L. Seidel, D. S. Lichtenberg, T. Song, and S. Zhang Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kahn, J. C. Allen, C. L. Seidel, and S. Zhang Insulin Inhibits Migration of Vascular Smooth Muscle Cells With Inducible Nitric Oxide Synthase Hypertension, January 1, 2000; 35(1): 303 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Claxton, M. W. Brands, S. M. Fitzgerald, and J. A. Cameron Inhibition of Nitric Oxide Synthesis Potentiates Hypertension During Chronic Glucose Infusion in Rats Hypertension, January 1, 2000; 35(1): 451 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cohen The potential clinical impact of 20 years of nitric oxide research Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1404 - H1407. [Full Text] [PDF] |
||||
![]() |
A. M. Kahn, A. Husid, T. Odebunmi, J. C. Allen, C. L. Seidel, and T. Song Insulin inhibits vascular smooth muscle contraction at a site distal to intracellular Ca2+ concentration Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E885 - E892. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. XUE, W. O. WILKISON, R. L. MYNATT, N. MOUSTAID, M. GOLDMAN, and M. B. ZEMEL The agouti gene product stimulates pancreatic {beta}-cell Ca2+ signaling and insulin release Physiol Genomics, July 15, 1999; 1(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |